Uploaded on Jan 24, 2023
Narcolepsy is a rare long-term brain disorder characterized by excessive sleepiness, sleep paralysis, hallucinations, and episodes of cataplexy among certain patients. Read More:- https://www.theinsightpartners.com/reports/narcolepsy-market
Narcolepsy Market - Projected Surge in Revenue Generation by 2027
Narcolepsy Market Global Analysis and Forecast to 2027
Published Date : Feb 2019
Email: [email protected]
Email: [email protected]
Report Studies
Narcolepsy Market to 2027- Global Analysis and Forecasts by Type (Narcolepsy
with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy), Product
[Central Nervous System (CNS) Stimulants, Sodium Oxybate, and
Antidepressants], and Distribution Channel (Hospital Pharmacies and Retail
Pharmacies)
2
Email: [email protected]
$50,000
Narcolepsy Market
$40,000
Value
$30,000
CAGR of 9.5%
$20,000
(2019 to 2027)
$10,000
$0
20XX 20XX 20XX 20XX 20XX
3
Email: [email protected]
Narcolepsy Market
Overview
The narcolepsy market size is estimated to reach US$ 4,537.9 million by 2027 from US$
2,026.8 million in 2018; it is estimated to grow at a CAGR of 9.5% during 2019-2027.
Narcolepsy is a rare long-term brain disorder characterized by excessive sleepiness, sleep
paralysis, hallucinations, and episodes of cataplexy among certain patients.
4
Email: [email protected]
Key Segment Market
Segment By Type:-
Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy)
Product [Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants]
Distribution Channel (Hospital Pharmacies and Retail Pharmacies)
5
Email: [email protected]
Company Profiles
Bioprojet
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals, Inc.
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
Shire (Acquired by Takeda)
Ligand Pharmaceuticals, Inc.
Novartis AG
Mylan N.V.
Shionogi Inc.
6
Download Sample Her
e
Email: [email protected]
By Geography
North America (the US, Canada, and Mexico)
Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)
Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East &
Africa)
South & Central America (Brazil, Argentina, and the Rest of South & Central America).
7
THANK
YOU! Phone : +1-646-491-9876
E-Mail : [email protected]
Comments